Forbes January 22, 2020
Abbott Laboratories glucose monitoring device FreeStyle Libre sales are soaring as Miles White ends his two-decade run as chief executive and big technology firms from Apple and Amazon to Alphabet’s Verily try to crack the lucrative global diabetes market.
But Abbott’s sales of the continuous blood glucose monitoring system Freestyle Libre are helping the global medical product company maintain its dominance of the worldwide market. FreeStyle Libre sales jumped nearly 60% in the fourth quarter to $534 million, the kind of revenue normally equated with blockbuster prescription drugs.
FreeStyle Libre is considered a landmark device because it helps continuously track blood sugar levels with people with diabetes who also don’t have to endure a finger prick for the test as...
Today's Sponsors
Today's Sponsor